SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-085548
Filing Date
2024-04-03
Accepted
2024-04-03 09:28:01
Documents
15
Period of Report
2024-04-03
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d651169d8k.htm   iXBRL 8-K 45923
2 EX-3.1 d651169dex31.htm EX-3.1 32615
3 EX-3.2 d651169dex32.htm EX-3.2 126467
  Complete submission text file 0001193125-24-085548.txt   373402

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA knte-20240403.xsd EX-101.SCH 2513
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE knte-20240403_lab.xml EX-101.LAB 17200
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE knte-20240403_pre.xml EX-101.PRE 10790
19 EXTRACTED XBRL INSTANCE DOCUMENT d651169d8k_htm.xml XML 3802
Mailing Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130 8582994699
Kinnate Biopharma Inc. (Filer) CIK: 0001797768 (see all company filings)

IRS No.: 824566526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39743 | Film No.: 24817089
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)